Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hugh R Barrett

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Atherosclerosis|December 25, 2009
Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese menEsther M M Ooi, Gerald F Watts, Dick C Chan, et al.
Lipids|May 13, 2010
Influence of simvastatin on apoB-100 secretion in non-obese subjects with mild hypercholesterolemiaHeiner K Berthold, Jessica Mertens, Julia Birnbaum, et al.
Metabolism: Clinical and Experimental|April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)Gerald F Watts, Dick C Chan, Jing Pang, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2016
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial HypercholesterolemiaDick C Chan, Jing Pang, P Hugh R Barrett, et al.
Clinical Endocrinology|November 24, 2006
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivoEsther M M Ooi, Gerald F Watts, Juying Ji, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 23, 2013
Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemiaLiesl V Heeks, Amanda J Hooper, Leon A Adams, et al.
Diabetes Care|May 30, 2008
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndromeEsther M M Ooi, Gerald F Watts, Dick C Chan, et al.
Diabetes Care|August 5, 2009
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndromeDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Asia Pacific Journal of Clinical Nutrition|November 29, 2007
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndromeEsther M M Ooi, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)|May 17, 2006
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndromeGerald F Watts, Juying Ji, Dick C Chan, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Atherosclerosis|December 25, 2009
Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese menEsther M M Ooi, Gerald F Watts, Dick C Chan, et al.
Lipids|May 13, 2010
Influence of simvastatin on apoB-100 secretion in non-obese subjects with mild hypercholesterolemiaHeiner K Berthold, Jessica Mertens, Julia Birnbaum, et al.
Metabolism: Clinical and Experimental|April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)Gerald F Watts, Dick C Chan, Jing Pang, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2016
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial HypercholesterolemiaDick C Chan, Jing Pang, P Hugh R Barrett, et al.
Clinical Endocrinology|November 24, 2006
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivoEsther M M Ooi, Gerald F Watts, Juying Ji, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 23, 2013
Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemiaLiesl V Heeks, Amanda J Hooper, Leon A Adams, et al.
Diabetes Care|May 30, 2008
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndromeEsther M M Ooi, Gerald F Watts, Dick C Chan, et al.
Diabetes Care|August 5, 2009
Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndromeDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Asia Pacific Journal of Clinical Nutrition|November 29, 2007
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndromeEsther M M Ooi, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)|May 17, 2006
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndromeGerald F Watts, Juying Ji, Dick C Chan, et al.
Pageof 15